According to Collegium Pharmaceutical 's latest financial reports the company's total assets are $1.14 B. A companyโs total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Year | Total assets | Change |
---|---|---|
2023-12-31 | $1.14 B | -2.63% |
2022-12-31 | $1.17 B | 69.65% |
2021-12-31 | $0.69 B | 7.49% |
2020-12-31 | $0.64 B | 110.2% |
2019-12-31 | $0.30 B | 5.17% |
2018-12-31 | $0.29 B | 114.83% |
2017-12-31 | $0.13 B | -16.32% |
2016-12-31 | $0.16 B | 65.8% |
2015-12-31 | $97.71 M | 1819.8% |
2014-12-31 | $5.09 M | -43.66% |
2013-12-31 | $9.03 M |
Company | Total assets | differencediff. | Country |
---|---|---|---|
United Therapeutics UTHR | $7.16 B | 526.86% | ๐บ๐ธ USA |
Agile Therapeutics
AGRX | $10.88 M | -99.05% | ๐บ๐ธ USA |
Horizon Therapeutics
HZNP | $9.29 B | 713.32% | ๐ฎ๐ช Ireland |
KemPharm KMPH | $0.11 B | -89.90% | ๐บ๐ธ USA |